Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001628280-22-011514
Filing Date
2022-04-29
Accepted
2022-04-29 16:02:28
Documents
1

Document Format Files

Seq Description Document Type Size
1 DEFA14A sgmo_proxyx2022xdefxsupple.htm DEFA14A 36075
  Complete submission text file 0001628280-22-011514.txt   37129
Mailing Address 7000 MARINA BLVD BRISBANE CA 94005
Business Address 7000 MARINA BLVD BRISBANE CA 94005 5109706000
SANGAMO THERAPEUTICS, INC (Filer) CIK: 0001001233 (see all company filings)

EIN.: 680359556 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-30171 | Film No.: 22875080
SIC: 2836 Biological Products, (No Diagnostic Substances)